NCT00250458View on ClinicalTrials.gov

Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea

PHASE3CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Migraine
Interventions
DRUG

Comparator: Rizatriptan

One dose Rizatriptan 10 mg orally disintegrating tablet / oral lyophilisate to treat one migraine attack.

DRUG

Comparator: Placebo

One dose matching placebo to Rizatriptan to treat one migraine attack.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00250458 - Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea | Biotech Hunter | Biotech Hunter